name | 丁玉凤 |
sex | female
|
age | 90 岁 |
hospital number | 528577 |
height | 160 cm |
weight | 65 kg |
BSA | 1.62 m2 |
APACHEⅡ | 16 分 |
Infection source | other
|
date | 2017/09/30 年/月/日 |
Sequential Organ Failure Assessment | 9 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | |
yes
|
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
美罗培南1.0g q8h |
|
vasoactive agent | norepinephrine
|
180 min |
|
min |
|
10800 min |
Temperature | 37 ℃ |
Heart Rate | 70 次/分 |
Breath | 18 次/分 |
Systolic pressure (SP) | 167 mmHg |
Diastolic pressure | 57 mmHg |
mean arterial pressure | 90 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 536.2 |
VO2 | 136.4 |
Ca-vO2 | 27.4 |
pH value | 7.42 |
PaO2 | 143 mmHg |
PaCO2 | 26 mmHg |
BE | -6.7 mmol/L(±2.3mmol/L) |
SaO2 | 99 % |
Blood lactic acid concentration, LAC | 1.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 317.8 mmHg |
pH value | 7.37 |
PcvO2 | 41 mmHg |
PcvCO2 | 33 mmHg |
BE | -5.6 mmol/L |
ScvO2 | 74 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.5 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 8 mmHg |
cardiac output | 4.97 L/min |
cardiac index | 3.07 L/min/m2 |
stroke volume | 71.0 ml |
Stroke Index | 43.8 ml/m2 |
ITBVI | 854 ml/m2 |
GEDVI | 684 ml/m2 |
EVLWI | 7.1 ml/kg |
PVPI | 1.3 |
SVRI | 2137 DSm2/cm5 |
CFI | 5.2 |
GEF | 29 % |
SVV | 8 % |
PPV | % |
dPmax | 2293 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 8 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.4 mm |
IVC(expiratory phase) | 1.8 mm |
respiratory variations of inferior vena cavae diameter | 25 % |
1.2 mm |
|
mm |
|
1.7 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.5 ℃ |
Heart Rate | 75 次/分 |
Breath | 19 次/分 |
Systolic Pressure | 152 mmHg |
Diastolic Pressure | 57 mmHg |
Mean Arterial Pressure | 84 mmHg |
Pcv-aCO2 | 2 mmHg |
DO2 | 500.9 |
VO2 | 96.9 |
Ca-vO2 | 21.6 |
PH value | 7.44 |
PaO2 | 129 mmHg |
PaCO2 | 26 mmHg |
BE | -5.9 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 1.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 286.7 mmHg |
PH value | 7.42 |
PcvO2 | 43 mmHg |
PcvCO2 | 28 mmHg |
BE | -5.5 mmol/L |
ScvO2 | 80 % |
Volume of input | 1500 ml |
Volume of output | 500 ml |
Volume of urine | 355 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 10 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 11 mmHg |
cardiac output | 4.48 L/min |
cardiac index | 2.77 L/min/m2 |
stroke volume | 59.7 ml |
Stroke Index | 36.9 ml/m2 |
ITBVI | 773 ml/m2 |
GEDVI | 619 ml/m2 |
EVLWI | 7.3 ml/kg |
PVPI | 1.5 |
SVRI | 2111 DSm2/cm5 |
CFI | 5.2 |
GEF | 29 % |
SVV | 13 % |
PPV | % |
dPmax | 1952 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 8 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.4 mm |
IVC(expiratory phase) | 1.8 mm |
Respiratory variations of inferior vena cavae diameter | 20 % |
1.5 mm |
|
mm |
|
1.9 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.9 ℃ |
Heart Rate | 90 次/分 |
Breath | 17 次/分 |
Systolic Pressure | 164 mmHg |
Diastolic Pressure | 60 mmHg |
Mean Arterial Pressure | 95 mmHg |
Pcv-aCO2 | 4 mmHg |
DO2 | 628.7 |
VO2 | 164.8 |
Ca-vO2 | 29.6 |
PH value | 7.45 |
PaO2 | 170 mmHg |
PaCO2 | 28 mmHg |
BE | -4 mmol/L |
SaO2 | 100 % |
Blood Lactic Acid Concentration | 1 mmol/L |
Oxygenation index (PaO2/FiO2) | 377.8 mmHg |
PH value | 7.43 |
PcvO2 | 46 mmHg |
PcvCO2 | 32 mmHg |
BE | -5 mmol/L |
ScvO2 | 74 % |
Volume of input | 2570 ml |
Volume of output | 1800 ml |
Volume of urine | 1515 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 18 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 5 mmHg |
cardiac output | 5.56 L/min |
cardiac index | 3.43 L/min/m2 |
stroke volume | 61.8 ml |
Stroke Index | 38.1 ml/m2 |
ITBVI | 848 ml/m2 |
GEDVI | 679 ml/m2 |
EVLWI | 2.1 ml/kg |
PVPI | 7.1 |
SVRI | 2097 DSm2/cm5 |
CFI | 5.8 |
GEF | 26 % |
SVV | 15 % |
PPV | % |
dPmax | 1877 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 8 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.6 mm |
IVC(expiratory phase) | 2.0 mm |
Respiratory variations of inferior vena cavae diameter | 22 % |
1.6 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 38 ℃ |
Heart Rate | 74 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 140 mmHg |
Diastolic Pressure | 57 mmHg |
Mean Arterial Pressure | 78 mmHg |
Pcv-aCO2 | 6 mmHg |
DO2 | 700.8 |
VO2 | 135.6 |
Ca-vO2 | 25.5 |
PH value | 7.4 |
PaO2 | 135 mmHg |
PaCO2 | 27 mmHg |
BE | -6.1 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 1.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 300 mmHg |
PH value | 7.38 |
PcvO2 | 42 mmHg |
PcvCO2 | 33 mmHg |
BE | -5.8 mmol/L |
ScvO2 | 80 % |
Volume of input | 4143 ml |
Volume of output | 3410 ml |
Volume of urine | 3030 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 36 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 11 mmHg |
cardiac output | 5.32 L/min |
cardiac index | 3.28 L/min/m2 |
stroke volume | 71.9 ml |
Stroke Index | 44.4 ml/m2 |
ITBVI | 893 ml/m2 |
GEDVI | 714 ml/m2 |
EVLWI | 7.5 ml/kg |
PVPI | 1.4 |
SVRI | 1631 DSm2/cm5 |
CFI | 5.3 |
GEF | 30 % |
SVV | 14 % |
PPV | % |
dPmax | 1804 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 12 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.6 mm |
IVC(expiratory phase) | 2.0 mm |
Respiratory variations of inferior vena cavae diameter | 22 % |
1.6 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 38.5 ℃ |
Heart Rate | 97 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 162 mmHg |
Diastolic Pressure | 75 mmHg |
Mean Arterial Pressure | 64 mmHg |
Pcv-aCO2 | 4 mmHg |
DO2 | 433.5 |
VO2 | 85.5 |
Ca-vO2 | 21.9 |
PH value | 7.43 |
PaO2 | 125 mmHg |
PaCO2 | 33 mmHg |
BE | -2.1 mmol/L |
SaO2 | 97 % |
Blood Lactic Acid Concentration | 1 mmol/L |
Oxygenation index (PaO2/FiO2) | 312.5 mmHg |
PH value | 7.40 |
PcvO2 | 50 mmHg |
PcvCO2 | 37 mmHg |
BE | -1.8 mmol/L |
ScvO2 | 78 % |
Volume of input | 7302 ml |
Volume of output | 5886 ml |
Volume of urine | 5330 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 36 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 10 mmHg |
cardiac output | 3.91 L/min |
cardiac index | 2.45 L/min/m2 |
stroke volume | 25.3 ml |
Stroke Index | 40.9 ml/m2 |
ITBVI | 687 ml/m2 |
GEDVI | 550 ml/m2 |
EVLWI | 6.3 ml/kg |
PVPI | 1.5 |
SVRI | 3067 DSm2/cm5 |
CFI | 5.1 |
GEF | 22 % |
SVV | 17 % |
PPV | % |
dPmax | 1254 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 12 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.8 mm |
IVC(expiratory phase) | 2.2 mm |
Respiratory variations of inferior vena cavae diameter | 20 % |
1.7 mm |
|
mm |
|
2.3 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.5 ℃ |
Heart Rate | 82 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 154 mmHg |
Diastolic Pressure | 88 mmHg |
Mean Arterial Pressure | 112 mmHg |
Pcv-aCO2 | 5 mmHg |
DO2 | 847.5 |
VO2 | 198.1 |
Ca-vO2 | 26.4 |
PH value | 7.44 |
PaO2 | 131 mmHg |
PaCO2 | 32 mmHg |
BE | -2.2 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 1.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 327.5 mmHg |
PH value | 7.41 |
PcvO2 | 48 mmHg |
PcvCO2 | 37 mmHg |
BE | -3 mmol/L |
ScvO2 | 76 % |
Volume of input | 7549 ml |
Volume of output | 7631 ml |
Volume of urine | 6980 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 36 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 11 mmHg |
cardiac output | 7.49 L/min |
cardiac index | 3.94 L/min/m2 |
stroke volume | 91.3 ml |
Stroke Index | 48.1 ml/m2 |
ITBVI | 915 ml/m2 |
GEDVI | 733 ml/m2 |
EVLWI | 6.3 ml/kg |
PVPI | 1.2 |
SVRI | 2049 DSm2/cm5 |
CFI | 5.5 |
GEF | 28 % |
SVV | 9 % |
PPV | % |
dPmax | 626 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 12 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 1.8 mm |
Respiratory variations of inferior vena cavae diameter | 2.0 % |
IVC(inspiratory phase) | 10 mm |
1.9 mm |
|
mm |
|
2.0 mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 720 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 79 umol/L |
Urea nitrogen | 2 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 10.1 X10*9/L |
neutrophilic granulocyte percentage | 62.3 % |
Hb | 81 g/L |
CRP | 42.26 mg/L |
Procalcitonin, PCT | 4.95 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 9 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 81 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 129 umol/L |
Urea nitrogen | 4.5 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 10.9 X10*9/L |
neutrophilic granulocyte percentage | 85.6 % |
Hb | 99 g/L |
CRP | 203.9 mg/L |
Procalcitonin, PCT | 2.7 ng/ml |
Sequential Organ Failure Assessment | 6 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 178 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 65 umol/L |
Urea nitrogen | 3.4 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 8.3 X10*9/L |
neutrophilic granulocyte percentage | 75.1 % |
Hb | 85 g/L |
CRP | 165 mg/L |
Procalcitonin, PCT | 1.69 ng/ml |
Sequential Organ Failure Assessment | 6 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 分 |
Complication |
prognosis | improve
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 天 |
duration in ICU | 24 天 |
duration of mechanical ventilation | 480 小时 |
ICU expenses | 165370 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |